ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02 (ORIC:NASDAQ)
ORIC Pharmaceuticals (ORIC) Q2 GAAP EPS -$0.38 misses by $0.02; cash/investments $387.6M funds operations into 2H 2028.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
ORIC Pharmaceuticals (ORIC) Q2 GAAP EPS -$0.38 misses by $0.02; cash/investments $387.6M funds operations into 2H 2028.
ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02 (ORIC:NASDAQ) | Seeking Alpha
ORIC Pharmaceuticals
press release
(
ORIC
): Q2 GAAP EPS of -$0.38
misses by $0.02
.
Cash, cash equivalents and investments totaled $387.6 million as of June 30, 2026, which includes $59.9 million in net proceeds raised from healthcare specialist funds during the first quarter under the ATM (at-the-market) program. The
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
TotalEnergies Subsidiary Hutchinson Secures $191.6M U.S. Army Tire Contract, Advancing Diversification Strategy
TotalEnergies' subsidiary Hutchinson has been awarded a U.S. Army contract worth up to $191.6 million for wheel and tire assemblies, bolstering its defense supply chain position and supporting the company's diversification strategy. The deal underscores the growing demand for military vehicle components amid global geopolitical tensions.
Douglas Dynamics Raises 2026 EPS Guidance to $2.90-$3.40, Lifts Net Sales Outlook to $765M-$805M
Douglas Dynamics raises its 2026 adjusted EPS guidance to $2.90-$3.40 and lifts net sales forecast to $765M-$805M, driven by resilient demand for snow and ice equipment. The stock offers attractive valuation with a forward P/E of ~15x.
Ingredion Q2 2026 Earnings Preview: Cost Pressures and Specialty Ingredients Growth in Focus
Ingredion is set to report Q2 2026 earnings, with investors eyeing specialty ingredients growth, cost management, and full-year guidance amid raw material volatility and mixed global demand.
AMD earnings: Sky-high expectations leave little room for missteps (AMD:NASDAQ)
AMD Q2 earnings Aug. 4: AI chip demand, data center growth, MI400 updates and valuation risks.
